Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound Gel
23 juil. 2024 08h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that the US Food and Drug Administration (FDA)...
Frontier Medicines Announces Milestone Payment in AbbVie Partnership, Following Advancement of Lead Candidates Targeting a Historically Undruggable Transcription Factor
23 juil. 2024 07h00 HE
|
Frontier Medicines
BOSTON and SOUTH SAN FRANCISCO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation (“Frontier” or the “Company”), a clinical-stage precision medicine company seeking to unlock...
Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 2024
22 juil. 2024 08h00 HE
|
Oxford BioTherapeutics
Oxford, UK and San Jose, California, 22 July 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based...
Kraig Biocraft Laboratories Further Expands Spider Silk Production Levels with Launch of Third Production Cycle
22 juil. 2024 07h05 HE
|
Kraig Biocraft Laboratories
Kraig Labs (OTCQB: KBLB) launched its third and largest production cycle of the 2024 spider silk production season.
Certa Therapeutics Receives EU Orphan Designation for FT011, a GPR68 Inhibitor Being Developed as an Anti-Fibrotic Treatment for Systemic Sclerosis
22 juil. 2024 03h00 HE
|
Certa Therapeutics
MELBOURNE, Australia, July 22, 2024 (GLOBE NEWSWIRE) -- Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic...
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
18 juil. 2024 19h08 HE
|
Artiva Biotherapeutics Inc.
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins
17 juil. 2024 07h00 HE
|
Draupnir Bio
Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins MP Healthcare and EIFO join existing investors, Gilde Healthcare...
BioProcess360 Partners launch dedicated Life Sciences investment fund to grow emerging bioprocessing tools and technologies
17 juil. 2024 05h15 HE
|
BioProcess360
BioProcess360 Partners announce the launch of a new investment fund to support businesses with the growth of emerging bioprocessing technologies
FLAG Therapeutics Announces Encouraging Preclinical Data from Studies of FLAG-003 for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
16 juil. 2024 09h00 HE
|
Flag Therapeutics, Inc.
FLAG Therapeutics Announces Encouraging Preclinical Data from Studies of FLAG-003 for the Treatment of Diffuse Intrinsic Pontine Glioma (DIPG)
Alkeus Pharmaceuticals Appoints Tamara Dillon as Chief Human Resources Officer
16 juil. 2024 09h00 HE
|
Alkeus Pharmaceuticals
Alkeus Pharmaceuticals appoints Tamara Dillon as Chief Human Resources Officer